The Science Accelerator is a facility within Innovation Park providing wet lab space for companies conducting life science, biotech, as well as biomedical research and development.
From technologies that support sustainable chemical production to the development of cancer therapeutics and diagnostics, our Science Accelerator companies are working on cutting-edge and impactful innovations.
In alphabetical order, here are the startups in the Science Accelerator:
Alexandria Geriatric Care
Delivering life-saving therapeutics to patients with debilitating ailments is an ongoing challenge faced by healthcare providers. Alexandria Geriatric Care is developing alternative formulations for medicines, like aspirin and insulin, that can be administered more easily to all patients.
The development of therapies that can better target tumors is critical for treating cancer more effectively. Bacchus Therapeutics is doing just that by developing medicines that specifically target cancer cells without impacting healthy cells to accelerate recovery.
Did you know that over 6,000 of the products you use in daily life contain ingredients made from petroleum? Capra Biosciences is working to change that using bioreactors to transform waste carbon into useful products, like retinol for cosmetics and more!
Biomedical research often requires scientists to deliver molecules inside cells to study their function. Celetrix has developed a technology that enables the highly efficient delivery of those molecules into cells.
Nonrenewable energy sources, such as fossil fuels, continue to be heavily utilized in industrial applications. To better mitigate their use, FFI Ionix is developing technologies that employ renewable energy for sustainable chemical production.
Engaging with students early in their academic careers, particularly those from economically challenged communities, is critical for sparking interest in science. Future Kings is a nonprofit, afterschool STEM (science, technology, engineering, and math) program for 6-12th graders in underserved communities, where students can conduct biomedical research firsthand.
Mental health conditions, such as post-traumatic stress disorder, are often difficult to diagnose due to an absence of precise detection tools. Polaris Genomics is working to change that by developing diagnostic tools for assessing individual risk of mental health disorders.
Early-stage biomedical research often requires the meticulous observation of animal models when determining whether a therapeutic can treat a particular disease effectively. Tracked Bio is developing an AI-based technology that will more accurately monitor the effects of potential medicines on these organisms, which will ultimately accelerate the time in which human patients can benefit from them.
Wound infections, whether occurring on the battlefield or in a hospital, remain a constant threat to human health. ZeoVation is creating anti-microbial materials designed to accelerate healing and minimize infection for wound treatment.